JP2007528883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007528883A5 JP2007528883A5 JP2007502261A JP2007502261A JP2007528883A5 JP 2007528883 A5 JP2007528883 A5 JP 2007528883A5 JP 2007502261 A JP2007502261 A JP 2007502261A JP 2007502261 A JP2007502261 A JP 2007502261A JP 2007528883 A5 JP2007528883 A5 JP 2007528883A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- amino
- carbonyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 nitro , Cyano, amino Chemical group 0.000 claims 36
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 19
- 125000006698 (C1-C3) dialkylamino group Chemical group 0.000 claims 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 125000006563 (C1-3) alkylaminocarbonyl group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 7
- 229910052801 chlorine Inorganic materials 0.000 claims 7
- 239000000460 chlorine Substances 0.000 claims 7
- 125000006842 cycloalkyleneimino group Chemical group 0.000 claims 7
- 229910052731 fluorine Inorganic materials 0.000 claims 7
- 125000006597 (C1-C3) alkylcarbonylamino group Chemical group 0.000 claims 6
- 125000006602 (C1-C3) alkylsulfonylamino group Chemical group 0.000 claims 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 6
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 6
- 239000011737 fluorine Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 4
- 125000003277 amino group Chemical group 0.000 claims 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 4
- 229910052794 bromium Inorganic materials 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000006576 di-(C1-C3-alkyl)-aminocarbonyl group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000002883 imidazolyl group Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000004434 sulfur atom Chemical group 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 3
- 125000006594 (C1-C3) alkylsulfony group Chemical group 0.000 claims 3
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- 125000006239 protecting group Chemical group 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- PRRYKQCBNLEMKK-UHFFFAOYSA-N 5-acetyl-3-[(3,4-difluorophenyl)-(2,2-dimethylhydrazinyl)methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=C(C(C)=O)C=C2C1=C(NN(C)C)C1=CC=C(F)C(F)=C1 PRRYKQCBNLEMKK-UHFFFAOYSA-N 0.000 claims 2
- GEDCCZDGOSWMCN-UHFFFAOYSA-N 5-acetyl-3-[8-(dimethylamino)oct-2-en-4-ylidene]-1h-indol-2-one Chemical compound C1=C(C(C)=O)C=C2C(=C(CCCCN(C)C)C=CC)C(=O)NC2=C1 GEDCCZDGOSWMCN-UHFFFAOYSA-N 0.000 claims 2
- RRIMEAIVEAJAJM-UHFFFAOYSA-N 5-acetyl-3-[phenyl(propylamino)methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=C(C(C)=O)C=C2C1=C(NCCC)C1=CC=CC=C1 RRIMEAIVEAJAJM-UHFFFAOYSA-N 0.000 claims 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 2
- 125000001769 aryl amino group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 125000005222 heteroarylaminocarbonyl group Chemical group 0.000 claims 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 2
- HCXMWFUMXGBEQA-UHFFFAOYSA-N methyl 4-[[(5-acetyl-2-oxo-1h-indol-3-ylidene)-(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]amino]butanoate Chemical compound O1CCOC2=CC(C(=C3C4=CC(=CC=C4NC3=O)C(C)=O)NCCCC(=O)OC)=CC=C21 HCXMWFUMXGBEQA-UHFFFAOYSA-N 0.000 claims 2
- FSQQJBYLRCHDQO-UHFFFAOYSA-N n-[3-[[(5-acetyl-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]propyl]methanesulfonamide Chemical compound C12=CC(C(=O)C)=CC=C2NC(=O)C1=C(NCCCNS(C)(=O)=O)C1=CC=CC=C1 FSQQJBYLRCHDQO-UHFFFAOYSA-N 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 1
- HFWLYTNHGAQFOU-UHFFFAOYSA-N 5-acetyl-3-[phenyl-(3-pyridin-3-ylpropylamino)methylidene]-1h-indol-2-one Chemical compound C12=CC(C(=O)C)=CC=C2NC(=O)C1=C(C=1C=CC=CC=1)NCCCC1=CC=CN=C1 HFWLYTNHGAQFOU-UHFFFAOYSA-N 0.000 claims 1
- OYSQUGVVMMVTHE-UHFFFAOYSA-N 5-acetyl-3-[phenyl-(propan-2-ylamino)methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=C(C(C)=O)C=C2C1=C(NC(C)C)C1=CC=CC=C1 OYSQUGVVMMVTHE-UHFFFAOYSA-N 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims 1
- 125000004658 aryl carbonyl amino group Chemical group 0.000 claims 1
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000002993 cycloalkylene group Chemical group 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 230000003412 degenerative effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000005241 heteroarylamino group Chemical group 0.000 claims 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 1
- 125000005224 heteroarylcarbonylamino group Chemical group 0.000 claims 1
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 150000003951 lactams Chemical group 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 claims 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- HFWLYTNHGAQFOU-VHXPQNKSSA-N CC(c(cc1)cc(/C2=C(\c3ccccc3)/NCCCc3cccnc3)c1NC2=O)=O Chemical compound CC(c(cc1)cc(/C2=C(\c3ccccc3)/NCCCc3cccnc3)c1NC2=O)=O HFWLYTNHGAQFOU-VHXPQNKSSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004012068A DE102004012068A1 (de) | 2004-03-12 | 2004-03-12 | Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel |
| US55947104P | 2004-04-05 | 2004-04-05 | |
| PCT/EP2005/002406 WO2005087727A1 (de) | 2004-03-12 | 2005-03-05 | Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007528883A JP2007528883A (ja) | 2007-10-18 |
| JP2007528883A5 true JP2007528883A5 (https=) | 2008-04-24 |
Family
ID=34987190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007502261A Pending JP2007528883A (ja) | 2004-03-12 | 2005-03-05 | 新規なアルキル含有５−アシルインドリノン、その製法及びその医薬品としての使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7560480B2 (https=) |
| EP (1) | EP1727799B1 (https=) |
| JP (1) | JP2007528883A (https=) |
| AR (1) | AR048009A1 (https=) |
| AT (1) | ATE420072T1 (https=) |
| CA (1) | CA2559139A1 (https=) |
| DE (2) | DE102004012068A1 (https=) |
| ES (1) | ES2320905T3 (https=) |
| UY (1) | UY28804A1 (https=) |
| WO (1) | WO2005087727A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7781475B2 (en) * | 2005-06-10 | 2010-08-24 | Merck Patent Gmbh | Oxindoles as kinase inhibitors |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2009092580A1 (en) * | 2008-01-25 | 2009-07-30 | Boehringer Ingelheim International Gmbh | Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| MX2012001729A (es) | 2009-08-26 | 2012-06-13 | Sanofi Sa | Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo. |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| US9492430B2 (en) | 2011-11-14 | 2016-11-15 | Ligand Pharmaceuticals, Incorporated | Methods and compositions associated with the granulocyte colony-stimulating factor receptor |
| KR102919209B1 (ko) | 2018-08-10 | 2026-01-28 | 다이아핀 테라퓨틱스, 엘엘씨 | 트리-펩타이드 그리고 대사, 심장혈관 및 염증성 장애의 치료 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19949209A1 (de) * | 1999-10-13 | 2001-04-19 | Boehringer Ingelheim Pharma | In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE102004012069A1 (de) | 2004-03-12 | 2005-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue aryl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel |
-
2004
- 2004-03-12 DE DE102004012068A patent/DE102004012068A1/de not_active Withdrawn
-
2005
- 2005-03-05 CA CA002559139A patent/CA2559139A1/en not_active Abandoned
- 2005-03-05 ES ES05715811T patent/ES2320905T3/es not_active Expired - Lifetime
- 2005-03-05 WO PCT/EP2005/002406 patent/WO2005087727A1/de not_active Ceased
- 2005-03-05 EP EP05715811A patent/EP1727799B1/de not_active Expired - Lifetime
- 2005-03-05 DE DE502005006424T patent/DE502005006424D1/de not_active Expired - Fee Related
- 2005-03-05 AT AT05715811T patent/ATE420072T1/de not_active IP Right Cessation
- 2005-03-05 JP JP2007502261A patent/JP2007528883A/ja active Pending
- 2005-03-10 US US11/077,399 patent/US7560480B2/en active Active
- 2005-03-11 UY UY28804A patent/UY28804A1/es not_active Application Discontinuation
- 2005-03-11 AR ARP050100966A patent/AR048009A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007528883A5 (https=) | ||
| JP2006504761A5 (https=) | ||
| JP2010521515A5 (https=) | ||
| JP2020523388A5 (https=) | ||
| RU2005133994A (ru) | Оксимные производные и их применение в качестве фармацевтически активных агентов | |
| JP2011513305A5 (https=) | ||
| JP2013538802A5 (https=) | ||
| JPWO2020094104A5 (https=) | ||
| JP2012507525A5 (https=) | ||
| BR112019019605A2 (pt) | composto, processos para preparar compostos, e, método | |
| JP5947724B2 (ja) | シクロフィリンの新しいインヒビター及びその使用 | |
| RU2014145819A (ru) | Бициклическое соединение | |
| CO6150176A2 (es) | Derivados de bencimidazol utiles en el tratamiento de los trastornos relacionados con el receptor vaniloide trpv1 | |
| CN1087740C (zh) | 新的苯并咪唑、苯并唑和苯并噻唑，它们的制备方法以及含有它们的药物组合物 | |
| CA2551788A1 (en) | Novel carboxamides for use as xa inhibitors | |
| RU2010113358A (ru) | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов | |
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| EP3807251A1 (en) | Phenyl and pyridinyl substituted imidazoles as modulators of roryt | |
| JPWO2023195529A5 (https=) | ||
| JP2008525400A5 (https=) | ||
| JP2015502371A5 (https=) | ||
| JP2007528882A5 (https=) | ||
| JP2017525717A5 (https=) | ||
| JP2004525173A5 (https=) | ||
| EA011638B1 (ru) | Ингибиторы транспорта глицина |